Team2024-10-24T15:25:14-04:00A Week of Policy Headlines & Our TakeTeam2024-10-24T15:25:14-04:0010/11/2024|
Team2024-10-08T15:31:02-04:00Abbott and Edwards Lifesciences Likely Successful TCET CandidatesTeam2024-10-08T15:31:02-04:0010/07/2024|
Team2024-10-07T17:15:52-04:00Humana & United Challenge CMS on StarsTeam2024-10-07T17:15:52-04:0010/04/2024|
Team2024-10-07T17:11:35-04:002027 Negotiated Drug Prices Potentially Start Lower?Team2024-10-07T17:11:35-04:0010/03/2024|
Team2024-10-07T17:07:57-04:00FDA AdComm Reform is Not Coming Any Time SoonTeam2024-10-07T17:07:57-04:0010/02/2024|
Team2024-10-07T17:05:16-04:00Deja Vu: Healthcare Takes Backseat in Vance v. WalzTeam2024-10-07T17:05:16-04:0010/02/2024|
Team2024-09-30T17:02:05-04:00Medicare Advantage Landscape Files 2025Team2024-09-30T17:02:05-04:0009/29/2024|
Team2024-09-30T16:58:19-04:00Health Policy Catalyst Update – The Week Ahead and BeyondTeam2024-09-30T16:58:19-04:0009/27/2024|
Team2024-09-30T16:55:59-04:00Medicaid MCO Guidance On Prior AuthTeam2024-09-30T16:55:59-04:0009/26/2024|
Team2024-09-30T16:51:57-04:00Novo CEO Testifies Today on GLP-1 PricesTeam2024-09-30T16:51:57-04:0009/24/2024|
Team2024-09-30T16:49:20-04:00Rare Pediatric Disease PRV Likely to Be Extended via Latest CRTeam2024-09-30T16:49:20-04:0009/23/2024|
